SEC 13F Intelligence

Morgens Waterfall Vintiadis & Co Inc / UTHR

Morgens Waterfall Vintiadis & Co Inc’s United Therapeutics Corp Del Position

Does Morgens Waterfall Vintiadis & Co Inc own United Therapeutics Corp Del (UTHR)? Not currently — the last reported position was 8.7K shares worth $2M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2023
Shares
8.7K
% of Portfolio
+1.60%
Quarters Held
4
position exited

Position History UTHR

Reported value by quarter
Q2 ’22: $754,000Q2 ’22Q3 ’22: $2MQ3 ’22Q4 ’22: $2MQ4 ’22Q1 ’23: $2MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20238.7K$2M+1.60%
Q4 20226.4K$2M+1.54%
Q3 202210.4K$2M+2.39%
Q2 20223.2K$754,000+0.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Morgens Waterfall Vintiadis & Co Inc’s full portfolio or all institutional holders of UTHR.